stella
beta
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma — Stella
Home
/
HCC
/
View on ClinicalTrials.gov
Recruiting
Back to HCC trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Egypt
NLI, Shibīn al Kawm, Menoufia